首页> 外文期刊>Science >β_2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses
【24h】

β_2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses

机译:β_2-肾上腺素能受体介导的2组先天性淋巴样细胞反应的负调控

获取原文
获取原文并翻译 | 示例
       

摘要

The type 2 inflammatory response is induced by various environmental and infectious stimuli. Although recent studies identified group 2 innate lymphoid cells (ILC2s) as potent sources of type 2 cytokines, the molecular pathways controlling ILC2 responses are incompletely defined. Here we demonstrate that murine ILC2s express the beta(2)-adrenergic receptor (beta(2)AR) and colocalize with adrenergic neurons in the intestine. beta(2)AR deficiency resulted in exaggerated ILC2 responses and type 2 inflammation in intestinal and lung tissues. Conversely, beta(2)AR agonist treatment was associated with impaired ILC2 responses and reduced inflammation in vivo. Mechanistically, we demonstrate that the beta(2)AR pathway is a cell-intrinsic negative regulator of ILC2 responses through inhibition of cell proliferation and effector function. Collectively, these data provide the first evidence of a neuronal-derived regulatory circuit that limits ILC2-dependent type 2 inflammation.
机译:2型炎症反应是由各种环境和感染性刺激引起的。尽管最近的研究将第2组先天性淋巴样细胞(ILC2)确定为2型细胞因子的有效来源,但控制ILC2反应的分子途径尚不完全清楚。在这里,我们证明了鼠ILC2s表达beta(2)-肾上腺素能受体(beta(2)AR)并与肾上腺素能神经元在肠道中共定位。 beta(2)AR缺乏导致肠道和肺组织中的ILC2反应过度和2型炎症。相反,β(2)AR激动剂治疗与受损的ILC2反应和体内炎症减少相关。从机制上讲,我们证明beta(2)AR途径是通过抑制细胞增殖和效应子功能来实现ILC2响应的细胞内负调节剂。总的来说,这些数据提供了神经元调节回路的第一个证据,该回路限制了ILC2依赖性2型炎症。

著录项

  • 来源
    《Science》 |2018年第6379期|1056-1061|共6页
  • 作者单位

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

    German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany;

    Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:04

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号